VAP-1 in chronic kidney disease and diabetic kidney disease

Journal Title: Postępy Nauk Medycznych - Year 2013, Vol 26, Issue 3

Abstract

VAP-1 (vascular adhesion protein-1) is a copper-containing SSAO (semi-carbazide sensitive amine oxidase) with dual function. It is secreted by vascular smooth muscle cells, adipocytes, and endothelial cells with functional monoamine oxidase activity. VAP-1 is elevated in hyperglycemia and chronic kidney disease.<br>The aim of the study was to assess VAP-1 levels and its correlations with renalase,which possesses possible monoamine oxidase activity, in patients on peritoneal dialyses in regard to the presence of diabetes.<br>We assessed adhesion moleculeas: P and E-selectins, ICAM i VCAM, CD40L,CD44, CD146 and some hemostatic parameters thrombin-antithrombin comlpexes-TAT, prothrombin fragments 1+2, plasmin-antiplasmin complexes PAP, tissue plasminogen activator-tPA and its inhibitor-PAI-1, VAP-1 and renalase with commercially available assays. Diabetic patients had higher VAP-1 and CD146 levels but lower renalase than non-diabetic subjects. In univariate analysis VAP-1 was related to time on dialyses, presence of diabetes, platelet count, CD146, and renalase was related to presence of diabetes, CD40L and PAP. In multivariate analysis, predictor of VAP-1 was only the presence of diabetes.<br>Concluding, VAP-1, elevated in patients on peritoneal dialyses was predominantly dependent the presence of diabetes, both factors associated with endothelial damage and promoting cardiovascular complications. Taking into consideration the principle of peritoneal dialysis, elevated VAP-1 and markers of endothelial cell damage might contribute to the enhanced progression of atherosclerosis in this population.

Authors and Affiliations

Ewa Koc-Żórawska, Jolanta Małyszko, Jacek Małyszko, Michał Myśliwiec

Keywords

Related Articles

Diagnosis of focal liver lesions – visualizing examinations<br /> or biopsy? Our experience

Introduction: Owing to wide availability of modern visualizing diagnostic methods focal liver lesions are often diagnosed.Material and Methods: The retrospective study was conducted involving the patients with focal live...

PRINCIPLES FOR RENAL REPLACEMENT THERAPY IN ACUTE KIDNEY INJURY

Despite a substantial technical progress in renal replacement therapy and intensive care medicine the mortality rate for severe acute kidney injury (AKI) remains very high. Moreover there is a lot of controversy in almos...

Mechaniczne udrażnianie zmian pierwotnych oraz nawrotowych w tętnicach oraz pomostach naczyniowych – wstępne doświadczenia własne

Wstęp. Miażdżyca jest najczęstszą chorobą tętnic kończyn dolnych i główną przyczyną ich przewlekłego niedokrwienia. Leczenie zaawansowanej choroby tętnic obwodowych wykonywane jest metodami klasycznej chirurgii (endarter...

The importance of thrombin inhibitors in the antithrombotic pharmacotherapy

Activation of blood coagulation is a physiological process which consists of a series of zymogens that can be converted by limited proteolysis to active enzymes leading to the generation of thrombin. Trombin is a multifu...

Diagnostic imaging in contemporary oncology

Diagnostic imaging has an important role in all stages of management of oncologic patients and its proper application leads not only to improved treatment results, but also to increased cost-effectiveness.The great numbe...

Download PDF file
  • EP ID EP54673
  • DOI -
  • Views 130
  • Downloads 0

How To Cite

Ewa Koc-Żórawska, Jolanta Małyszko, Jacek Małyszko, Michał Myśliwiec (2013). VAP-1 in chronic kidney disease and diabetic kidney disease. Postępy Nauk Medycznych, 26(3), -. https://europub.co.uk./articles/-A-54673